195 related articles for article (PubMed ID: 17541170)
1. Antimicrobial activity of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant enterococci (VRE).
Horiuchi K; Shiota S; Hatano T; Yoshida T; Kuroda T; Tsuchiya T
Biol Pharm Bull; 2007 Jun; 30(6):1147-9. PubMed ID: 17541170
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of antimicrobial activity of aminoglycosides by carnosol from Salvia officinalis.
Horiuchi K; Shiota S; Kuroda T; Hatano T; Yoshida T; Tsuchiya T
Biol Pharm Bull; 2007 Feb; 30(2):287-90. PubMed ID: 17268067
[TBL] [Abstract][Full Text] [Related]
3. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
Sader HS; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin resistance reversal in enterococci by flavonoids.
Liu LX; Durham DG; Richards RM
J Pharm Pharmacol; 2001 Jan; 53(1):129-32. PubMed ID: 11206187
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activities of naphthazarins from Arnebia euchroma.
Shen CC; Syu WJ; Li SY; Lin CH; Lee GH; Sun CM
J Nat Prod; 2002 Dec; 65(12):1857-62. PubMed ID: 12502328
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of calozeyloxanthone isolated from Calophyllum species against vancomycin-resistant Enterococci (VRE) and synergism with antibiotics.
Sakagami Y; Kajimura K; Wijesinghe WM; Dharmaratne HR
Planta Med; 2002 Jun; 68(6):541-3. PubMed ID: 12094300
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin.
Perri MB; Hershberger E; Ionescu M; Lauter C; Zervos MJ
Diagn Microbiol Infect Dis; 2002 Apr; 42(4):269-71. PubMed ID: 12007445
[TBL] [Abstract][Full Text] [Related]
10. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M
Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
[TBL] [Abstract][Full Text] [Related]
11. A novel high-resolution melting analysis approach for rapid detection of vancomycin-resistant enterococci.
Ozbak HA
Ann Saudi Med; 2018; 38(3):200-207. PubMed ID: 29848938
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Garrison MW; Nuemiller JJ
Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Fresh Produces and Human Fecal Samples.
Kim MC; Cha MH; Ryu JG; Woo GJ
Foodborne Pathog Dis; 2017 Apr; 14(4):195-201. PubMed ID: 28346839
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae.
Patel R; Rouse MS; Piper KE; Cockerill FR; Steckelberg JM
Diagn Microbiol Infect Dis; 1998 Feb; 30(2):89-92. PubMed ID: 9554174
[TBL] [Abstract][Full Text] [Related]
15. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci.
Baltch AL; Smith RP; Ritz WJ; Bopp LH
Chemotherapy; 2001; 47(4):250-60. PubMed ID: 11399861
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial action of oleanolic acid on Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis.
Kim S; Lee H; Lee S; Yoon Y; Choi KH
PLoS One; 2015; 10(3):e0118800. PubMed ID: 25756202
[TBL] [Abstract][Full Text] [Related]
18. Anti-vancomycin-resistant Enterococcus faecium and E. faecalis activities of (-)-gossypol and derivatives from Thespesia garckeana.
Masila VM; Midiwo JO; Zhang J; Gisacho BM; Munayi R; Omosa LK; Wiggers FT; Jacob MR; Walker LA; Muhammad I
Nat Prod Commun; 2015 Apr; 10(4):613-6. PubMed ID: 25973489
[TBL] [Abstract][Full Text] [Related]
19. Immunological responses against vancomycin-resistant Enterococcus faecium and Enterococcus faecalis by mice.
Cho YS; Lee MH; Kim JM; Lee HS; Yoo HS; Park YH; Ryu PD
J Immunoassay Immunochem; 2018; 39(2):163-172. PubMed ID: 29308974
[TBL] [Abstract][Full Text] [Related]
20. [Vancomycin resistant enterococci in the Netherlands].
Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
